WallStSmart
CRNX

Crinetics Pharmaceuticals Inc

NASDAQ: CRNX · HEALTHCARE · BIOTECHNOLOGY

$38.44
+0.76% today

Updated 2026-04-29

Market cap
$3.99B
P/E ratio
P/S ratio
519.04x
EPS (TTM)
$-4.95
Dividend yield
52W range
$26 – $58
Volume
1.1M

Crinetics Pharmaceuticals Inc (CRNX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-8.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-46.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.0%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-5.9%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$-1.29-0.8%$40.12$38.90-3.0%
2025-11-06$-1.38-10.4%$42.53$40.00-5.9%
2025-08-07$-1.23-11.8%$28.53$26.85-5.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.28$-1.29-0.8%$3.88M
2025-09-30$-1.25$-1.38-10.4%$143000.00
2025-06-30$-1.10$-1.23-11.8%$1.03M+158.4%
2025-03-31$-0.95$-1.04-9.2%$361000.00-43.6%
2024-12-31$-0.89$-0.88+1.3%
2024-09-30$-0.91$-0.96-5.5%
2024-06-30$-0.86$-0.94-9.3%$399000.00-59.6%
2024-03-31$-0.81$-0.93-14.8%$640000.00-76.1%
2023-12-31$-0.86$-0.90-4.7%
2023-09-30$-0.86$-1.01-17.4%$346000.00
2023-06-30$-0.86$-0.94-9.3%$988000.00
2023-03-31$-0.81$-0.85-4.9%$2.68M

Frequently asked questions

Has Crinetics Pharmaceuticals Inc beaten earnings estimates?
Crinetics Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -8.1% over the last 4 quarters.
How does CRNX stock react to earnings?
CRNX stock has moved an average of -5.0% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.